Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 16 Aug 2016
ABSCH-IRCC-IN-207620-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/640
Application in Form-III for seeking approval for the invention “A recombinant mastrevirus as a viral vector system” for obtaining IP Rights in India, China, Pakistan, European Union, Australia, United States of America and South Africa.
30 Dec 2014
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Organization:National Agri-Food Biotechnology Institute (NABI)Academic or research instituteDirector,C-127, Industrial Area, Phase VIII, S.A.S. Nagar,Mohali, Punjab
160071, IndiaPhone: +91 172 4990300, +91 172 2290300,Fax:Email: edoffice@nabi.res.in,Website: http://nabi.res.in/,
Confidential information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days thereof.
2. If the user himself commercializes the process/product/innovation, he shall pay royalty @ 3% of the highest ex-factory sale price of the product(s) sold or used for captive consumption.
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention “A recombinant mastrevirus as a viral vector system" in India, China, Pakistan, European Union, Australia, United States of America and South Africa
Biological Resource: Wheat Dwarf India Virus, Ageratum yellow Leaf Curl Beta-satellite and Cotton Leaf Curl Burewala alphasatellite
Confidential information
- Commercial
1. In case the user assigns/licenses the innovation/ process/ product to a third party for commercialization:
The Applicant shall pay 5% of the fee received by him in any form (including the license fee / assignee fee). He shall also pay 5% of the annual royalty amount received by him, on an annual basis, from the assignee/ licensee throughout the term of the agreement.
OR
The assignee/licensee shall enter into a tripartite agreement with the Applicant and the NBA, to pay 5% of the lump sum payment made by him to the licensor and also royalty @ 5% of the highest ex-factory sale price of the product sold and also used for captive consumption to NBA.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-207620-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
16 Aug 2016 12:00 on 16 Aug 2016 12:00
|
